Concepedia

Xiaohua Xin

XX

Statistics

Publications

21

Citations

4.3K

H-Index

18

Active since

1994

Affiliations

University of North Carolina at Chapel Hill(Current)

Sunesis (United States)

Stanford University

Hospital Universitario Fundación Jiménez Díaz

Pfizer (United States)

Xiaohua Xin is an author at University of North Carolina at Chapel Hill specializing in pharmacology, life sciences, and medicine.

Publications per year

1994–2021

21

Publications

21

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

Dirk B. Mendel, Alexander Laird, Xiaohua Xin et al. · PubMed · 2003 · 2K citations

Medicine, Oncology, Pharmacology +15

Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo

Xiaohua Xin, Joe Kowalski, Mary E. Gerritsen · Journal of Biological Chemistry · 1999 · 513 citations · Full text

Medicine, Molecular Biology, Pharmacology +14

Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo

Xiaohua Xin, Gladys S. Ingle, Constance Zlot et al. · American Journal Of Pathology · 2001 · 397 citations · Full text

Medicine, Cancer Biology, Hepatology +8

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer

Matthew T. Burger, Sabina Pecchi, Allan S. Wagman et al. · ACS Medicinal Chemistry Letters · 2011 · 251 citations · Full text

Pharmacy, Oncology, Pharmacology +13

Gene Expression Profiling in an in Vitro Model of Angiogenesis

Jeanne W. Kahn, Fuad Mehraban, Gladys S. Ingle et al. · American Journal Of Pathology · 2000 · 177 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

1–5 of 21